Preoperative hemoglobin A1c is associated with postoperative bleeding after vitrectomy for vitreous hemorrhage in patients with diabetic retinopathy

• Published in: Endocrine Journal Vol. 71; no. 10; pp. 965 - 971
• Main Authors: Motoda, Saori, Kanai, Masanori, Sakimoto, Susumu, Ozawa, Harutoshi, Ishibashi, Chisaki, Fujita, Shingo, Hosokawa, Yoshiya, Baden, Megu Y., Fujita, Yukari, Kimura, Takekazu, Tokunaga, Ayumi, Nammo, Takao, Fukui, Kenji, Kozawa, Junji, Sakaguchi, Hirokazu, Nishida, Kohji, Shimomura, Iichiro
• Format: Journal Article
• Language: English
• Published: Japan The Japan Endocrine Society 01.01.2024
• Subjects: Diabetic retinopathy; Hemoglobin A1c (HbA1c); Postoperative bleeding; Vitrectomy; Diabetic retinopathy; Hemoglobin A1c (HbA1c); Vitrectomy; Postoperative bleeding
• ISSN: 0918-8959; 1348-4540; 1348-4540
• DOI: 10.1507/endocrj.EJ23-0301

We previously reported that a high HbA1c level 3 months before vitrectomy for vitreous hemorrhage or a large preoperative decrease in the HbA1c level over 3 months tended to increase the risk of rebleeding in diabetic retinopathy patients evaluated between 2010 and 2014. Here, we aimed to confirm these results with an extended study period and an increased number of operated eyes. This study included 121 diabetic patients who were admitted to Osaka University Hospital between 2010 and 2019 and who underwent vitrectomy for vitreous hemorrhage. Binomial logistic regression analysis was performed with the presence of postoperative bleeding as the outcome. The present study showed that the duration of the operation was associated with rebleeding (odds ratio = 1.02, p = 0.0016). A high HbA1c level just before vitrectomy tended to be associated with the bleeding (odds ratio = 1.27, p = 0.05), while preoperative HbA1c changes were not associated with rebleeding. The results of this study suggest that a high preoperative HbA1c level just before vitrectomy, not a decrease in HbA1c levels, in addition to the duration of the operation may increase the risk of postoperative bleeding after vitrectomy in diabetic retinopathy patients.